Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo : data to guide future paediatric vaccination strategies
Source
Vaccine - ISSN 0264-410X-89 (2026) p.